CARBOGEN AMCIS combines world-class chemistry skills to provide seamless drug development and commercialization services for leading pharmaceutical and biotechnology companies. Through our customised offering we provide an array of integrated services to support the fast supply of complex Antibody Drug Conjugates (ADCs). Our infrastructure is fully GMP compliant and includes a workshop dedicated to ADCs in Switzerland and a formulation site with lyophilization capabilities in France.
A Germany/Bavarian based company that offers a unique selection of payloads for ADCs. We provide state of the art molecules as well as contract manufactured payloads – derived from fermentation, soil, algae or chemically sythesized. Non GMP for early R&D up to cGMP for APIs made in Europe. Our reliability, flexibility, independence and reputation are our key success factors.
Genovis provides unique enzymes suitable for development and characterization of ADCs, mAbs, proteins, Fc-fusion proteins and biosimilars. The SmartEnzymes™ portfolio consists of:
- FabRICATOR® (IdeS), FabRICATOR®Z (IdeZ), FabULOUS® (SpeB) and GingisKHAN™ (Kgp). These enzymes are for preparation of subunits for further analysis using LC and MS.
- IgGZERO® (EndoS) and GlycINAT… Read More.
NOF Corporation is the leading commercial supplier of activated PEG products and is providing site-specific linkers, such as, linear and branched hetero-activated PEG, and single molecular weight PEGs for the development of next generation Antibody-Drug Conjugates. NOF also supplies ultra-pure polysorbates 20 and 80 for stabilizing the formulation of antibody and protein… Read More.
Formed in 2016, PROVEO™ is a four-company CMO alliance providing seamless, end-to-end solutions for the process development and cGMP manufacture of ADCs. Combining integrated project management, logistics, supply chain, and production—the PROVEO Alliance blends decades of industry experience and competencies with proven capabilities and the very latest in technological innovation to deliver an unmatched quality, dependability, and… Read More.
Quanta BioDesign was founded for the purpose of developing a line of products involved in drug discovery and diagnostic development. For 30 years the PEGylation of biologics has been completely defined by the use of generally high MW and highly polydispersed PEGs. While showing promising results in the clinic, it has serious limitations in control and characterization. Our single molecular weight ethylene glycol conjugation technology, dPEG, can eliminate common problems found in the development of diagnostic and therapeutic products.